Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Established Chemotherapy-Induced Neuropathy With Fingolimod: A Pilot Trial

NCT03943498 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03943498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03943498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Established Chemotherapy-Induced Neuropathy With Fingolimod: A Pilot Trial
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
May 24, 2019
Completion date
December 10, 2020
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy, numbness, pain, tingling